Melatonin per Cambiamenti del sonno legati all'età

Basato su 3 studi (1 RCT) con 30 partecipanti totali. 3/3 studi mostrano effetti positivi.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dage\u002Drelated\u002Dsleep\u002Dchanges'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

In sintesi

Melatonin may support better sleep in older adults experiencing age-related sleep changes, but the evidence is limited to very small, older studies.

All 3 studies show positive effects, but only 30 total participants
Includes 1 RCT specifically on melatonin for age-related insomnia
Studies are over 20 years old (1999-2001) — newer research is needed
Natural melatonin production declines with age, which supports the rationale for supplementation

Key Study Findings

Controlled Clinical Trial n=24 2 weeks

D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats.

Dose: 10 mg/kg body weight vs: Sodium arsenite group (SA, no riboceine) Outcome: Hepato-nephrotoxicity markers (ALT, AST, creatinine) Effetto: None None

Popolazione: Rats with sodium arsenite-induced toxicity

Randomized Controlled Trial 4 weeks Double-blind

Melatonin treatment for age-related insomnia.

Dose: Melatonin (timed-release or fast-release) vs: Placebo Outcome: Sleep onset and quality in elderly insomniacs Effetto: Improved sleep onset latency in elderly None

Popolazione: Older people with age-related insomnia

Review

The use of melatonin for the treatment of insomnia.

Dose: None vs: None Outcome: sleep quality Effetto: None None

Popolazione: critically ill patients

Other

Sulphur acquisition by Neisseria meningitidis.

Dose: None vs: None Outcome: oxidative stress markers Effetto: None None

Popolazione: athletes

Key Statistics

Studi

Partecipanti

↑

Positive

Grado

Referenced Papers

D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats. Other

Nigerian journal of … 2025

Melatonin treatment for age-related insomnia. RCT

The Journal of … 2001 305 citazioni

Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. Review

CNS drugs 2001 135 citazioni

The use of melatonin for the treatment of insomnia. Review

Biological signals and … 1999 48 citazioni

Sulphur acquisition by Neisseria meningitidis. Other

Canadian journal of … 1984 22 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:: 0.5-3 mg, 30-60 min before bed
jetlag:: 0.5-5 mg

Limite massimo: No established UL; 5 mg typically considered maximum

Dosaggi studiati nella ricerca

Dosaggio	Durata	Effetto	N
10 mg/kg body weight	2 weeks	Positive	24
Melatonin (timed-release or fast-release)	4 weeks	Positive	--
None	--	Positive	--
None	--	Positive	--

Momento migliore per l'assunzione: 30-60 minutes before bed

Safety & Side Effects

Effetti collaterali segnalati

⚠ Daytime drowsiness
⚠ Headache
⚠ Dizziness
⚠ Nausea
⚠ Vivid dreams or nightmares

Interazioni note

● Blood thinners (warfarin) — may increase bleeding risk
● Immunosuppressants — melatonin may stimulate immune function
● Diabetes medications — may affect blood sugar levels
● Sedatives and CNS depressants — additive drowsiness

Livello di assunzione massimo tollerabile: No established UL; 5 mg typically considered maximum

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Melatonin help with Cambiamenti del sonno legati all'età?

Based on 5 studies with 24 participants, there is moderate evidence from clinical studies that Melatonin may support Cambiamenti del sonno legati all'età management. Our evidence grade is B (Good Evidence).

How much Melatonin should I take for Cambiamenti del sonno legati all'età?

Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Melatonin?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Melatonin and Cambiamenti del sonno legati all'età?

We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 24 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Cambiamenti del sonno legati all'età

Magnesium L-Threonate D

Melatonin per altre condizioni

Insonnia A Disturbo del ritmo circadiano A Jet lag A Disturbo del sonno da lavoro a turni A Difficoltà di addormentamento A

Verdetto rapido

Basato su 3 studi (1 RCT) con 30 partecipanti totali. 3/3 studi mostrano effetti positivi.

Evidence Strength72%

High confidence

Analisi degli studi

RCT (1)Meta (0)Other (4)

Confronta le alternative

Scoprite come si confrontano altri ingredienti per questa condizione.

Visualizza tutti gli ingredienti per Cambiamenti del sonno legati all'età

Approfondimenti

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.